Pediatric hematuria as a gateway to family genetic investigation in type IV collagen nephropathies: experience from a regional cohort

Journal of Nephrology · Published 2026-04-08 · DOI 10.1093/joneph/aajag086

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/joneph/aajag086

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Genetics in Medicine · 2015 · Cites or is cited by this article
• Improving eGFR estimation in diabetic populations: insights from real-world data · Journal of Nephrology · 2026 · Same journal
• An 84-year-old man presenting with febrile cytopenia and acute glomerular disease. Lessons for the Clinical Nephrologist · Journal of Nephrology · 2026 · Same journal
• Decoding hemodialysis patients' symptoms: navigating the complexity · Journal of Nephrology · 2026 · Same journal
• Prenatal exposure to environmental toxicants and their association with alterations in kidney development · Journal of Nephrology · 2026 · Same journal
• Hidden glyoxylic acid in hair straightening products: a forensic lesson for the nephrologist · Journal of Nephrology · 2026 · Same journal
• The association between plasma aldosterone level, transtubular potassium gradient, or their ratios and causes of hyperkalemia in the outpatient setting · Journal of Nephrology · 2026 · Same journal
• Association of pre-donation microalbuminuria with accelerated kidney function impairment in living kidney donors: a retrospective cohort study · Journal of Nephrology · 2026 · Same journal
• Efficacy and safety of finerenone with or without combination therapy in patients with non-diabetic chronic kidney disease: a real-world observational study · Journal of Nephrology · 2026 · Same journal
• Telitacicept treatment for active antibody-mediated rejection after kidney transplantation: a case series · Journal of Nephrology · 2026 · Same journal